Literature DB >> 11954673

The JNK/c-Jun cascade and Alzheimer's disease.

Hitohi Okazawa1, Steven Estus.   

Abstract

Emerging evidence indicates that the JNK/c-Jun cascade is activated in neurons of the Alzheimer's disease brain and suggests its involvement in abnormal processes, ranging from tau phosphorylation to neuronal death. Substantial new data have accumulated on the functional relevance of causative genes in familial Alzheimer's disease and the pathological processes that occur within neurons. In this review, we summarize reported findings of the JNK/c-Jun cascade in Alzheimer's disease and discuss the relationship between the cascade and other pathological processes. We suggest that the effort to connect amyloid deposition with intracellular activation of the JNK/c-Jun cascade may modify the amyloid theory of Alzheimer's disease. Therapeutic approaches targeting the JNK/c-Jun cascade and other signaling may complement therapeutic strategies directed at reducing amyloid deposition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11954673     DOI: 10.1177/153331750201700209

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  20 in total

Review 1.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

2.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Endoplasmic reticulum enrollment in Alzheimer's disease.

Authors:  Ricardo J S Viana; Ana F Nunes; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-20       Impact factor: 5.590

Review 4.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 5.  Nuclear and cytosolic JNK signalling in neurons.

Authors:  Eleanor T Coffey
Journal:  Nat Rev Neurosci       Date:  2014-05       Impact factor: 34.870

6.  Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation.

Authors:  Quan-Guang Zhang; Ruimin Wang; Mohammad Khan; Virendra Mahesh; Darrell W Brann
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

7.  Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.

Authors:  Zikra Zulfiqar; Fawad Ali Shah; Shagufta Shafique; Abdullah Alattar; Tahir Ali; Arooj Mohsin Alvi; Sajid Rashid; Shupeng Li
Journal:  J Inflamm Res       Date:  2020-12-24

Review 8.  p73: a multifunctional protein in neurobiology.

Authors:  Richard Killick; Maria Niklison-Chirou; Richard Tomasini; Daniele Bano; Alessandro Rufini; Francesca Grespi; Tania Velletri; Paola Tucci; Berna S Sayan; Franco Conforti; Ewen Gallagher; Pierluigi Nicotera; Tak W Mak; Gerry Melino; Richard A Knight; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2011-03-08       Impact factor: 5.590

Review 9.  ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology.

Authors:  Antero Salminen; Anu Kauppinen; Tiina Suuronen; Kai Kaarniranta; Johanna Ojala
Journal:  J Neuroinflammation       Date:  2009-12-26       Impact factor: 8.322

10.  Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila.

Authors:  Andrew Rallis; Bingwei Lu; Julian Ng
Journal:  J Cell Sci       Date:  2012-12-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.